Prediction of Long‐Term Survival in Chronic Heart Failure by Multiple Biomarker Assessment: A 15‐Year Prospective Follow‐Up Study
Why the study?
Does baseline plasma ANP level predict 15-year all-cause mortality in outpatients with chronic heart failure?
Population
106 consecutive outpatients with chronic heart failure (CHF), median age 56 years, 85 male and 21 female.
Design
Cohort
Follow-up
15 years
Authors
Discussion
Loading...
Member takes
Implication
Baseline plasma ANP levels are a strong, independent predictor of very-long-term (15-year) all-cause mortality in patients with chronic heart failure.
Structured PICO
Does baseline plasma ANP level predict 15-year all-cause mortality in outpatients with chronic heart failure?
P
Population
106 consecutive outpatients with chronic heart failure (CHF), median age 56 years, 85 male and 21 female.
I
Intervention
Assessment of baseline plasma biomarkers including atrial natriuretic peptide (ANP), aldosterone, erythropoietin, and plasma renin activity.
O
Outcome
All-cause mortality at 15 years follow-up.hard clinical
Baseline plasma ANP levels are a strong, independent predictor of very-long-term (15-year) all-cause mortality in patients with chronic heart failure.
Cite This Study
Volpe et al. (2010) studied this question.